Results

Total Results: 1,187 records

Showing results for "week".

261. AHRQ Slide Template 2009 (ppt file)
     effectivehealthcare.ahrq.gov/sites/default/files/topic-refinement.ppt
     March 01, 2010 - of evidence on cancer incidence from non-CF patients receiving modest doses of rhGH (0.2 mg/kg per week … to 0.6 mg/kg per week) for disorders such as growth hormone deficiency and idiopathic short stature? … of evidence on cancer incidence from non-CF patients receiving modest doses of rhGH (0.2 mg/kg per week … to 0.6 mg/kg per week) for disorders such as growth hormone deficiency and idiopathic short stature?

262. Arthritis and Nontraumatic Joint Disease (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/arthritis_hi_impact.pdf
     January 01, 2014 - 100% and 70% of patients who had normalized PUA during the original phase II trials, in the 2- and 4-week … No incidence of gout flares was reported in the 2-week arm after 5-months. … intra-articular injection of an autologous PRP (n = 30) or hyaluronic acid injections (n = 30). 54 By week … twice daily, adalimumab (Humira®; Abbott Laboratories, Abbott Park, IL) 40 mg injected every other week

263. Obesity (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/obesity-horizon-scan-high-impact-1512.pdf
     December 01, 2015 - In late November 2015, about 26 weeks after product launch, about 2,300 Saxenda prescriptions per week … were reported to have been sold, up from 1,900 per week reported in mid-September 2015 … in late November 2015, about 26 weeks after product launch, about 2,300 Saxenda prescriptions per week … were reported to have been sold, up from 1,900 per week reported in September 2015.74 As of November

264. PULMONARY with "Discussions" in Exec Summary (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pulmonary-horizon-scan-high-impact-1412.pdf
     October 01, 2015 - Patients are ES-5 titrated to the full dose by the third week of therapy. … program to facilitate nintedanib diffusion; it features nurse-support access 24 hours a day, 7 days a week … vs. 15%), and headache (22% vs. 19%).26 In two replicate, phase III, randomized, double-blind, 52-week … clinical training for the OCS Lung was $100,000, and clinical field support 24 hours a day, 7 days a week … Two 24-week phase 3 studies of lumacaftor in combination with ivacaftor met primary endpoint with

265. Effects of Dietary Sodium and Potassium Intake on Chronic Disease (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/sodium-potassium_research-protocol.pdf
     April 18, 2017 - Effects of Dietary Sodium and Potassium Intake on Chronic Disease Evidence-based Practice Center Systematic Review Protocol Project Title: Effects of Dietary Sodium and Potassium Intake on Chronic Disease …

266. Obesity (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/obesity-horizon-scan-high-impact-1506.pdf
     June 01, 2015 - various pharmacies, with most requiring the use of a coupon.61 Based on recommended dosing, after the 5-week … announces the presentation of Orbera intragastric balloon us pivotal trial results at Digestive Disease Week … announces-the-presentation-of-orbera- intragastric-balloon-us-pivotal-trial-results-at- digestive-disease-week … apollo-endosurgery-inc-announces-the-presentation-of-orbera-intragastric-balloon-us-pivotal-trial-results-at-digestive-disease-week … apollo-endosurgery-inc-announces-the-presentation-of-orbera-intragastric-balloon-us-pivotal-trial-results-at-digestive-disease-week

267. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/high-cholestorol-medications_disposition-comments.pdf
     March 10, 2010 - effectiveness research review is posted to the Web site in draft form for public comment for a four-week … Methods from publication described below: “In this study, following a 6-week double-blind phase in which … patients received rosuvastatin 5 mg, rosuvastatin 10 mg, or placebo, patients were force-titrated at 6-week … intervals in an 18-week, open-label phase in Report and appendices revised accordingly for the study … "For the endpoint analysis, any dropout before Week 12 would be included in the analysis as long as

268. Disposition of Comments for Epoetin and Darbepoetin for Managing Anemia in Patients Undergoing Cancer Treatment (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cancer-anemia-update_disposition-comments.pdf
     April 25, 2013 - effectiveness research review is posted to the EHC Program Web site in draft form for public comment for a 4-week … The model assumes a 12-week course of ESA during chemotherapy, but the analysis where the 15% risk is … When underlying risk is included in the analyses for a 7.5% 16-week on-study mortality rate, the pooled … to either treatment and that these patients’ hemoglobins would eventually improve to 11 g/dL after week

269. Comparative Effectiveness Review No. 272_Genitourinary Syndrome of Menopause: A Systematic Review (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-272-genitourinary-syndrome-executive-summary.pdf
     July 01, 2024 - Comparative Effectiveness Review No. 272_Genitourinary Syndrome of Menopause: A Systematic Review Comparative Effectiveness Review Number 272 Genitourinary Syndrome of Menopause: A Systematic Review Executive Summary Main Points • One hundred seven publications of hormonal, non-hormonal moisturiz…

270. Traumatic-Brain-Injury-Rehabilitation Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/traumatic-brain-injury-rehabilitation_executive.pdf
     June 01, 2012 - 1 Comparative Effectiveness Review Number 72 Multidisciplinary Postacute Rehabilitation for Moderate to Severe Traumatic Brain Injury in Adults Executive Summary Background Condition and Therapeutic Strategies Traumatic brain injury (TBI) is an alteration in brain function or other evidence of brain patho…

271. Asthma-Treatment Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/asthma-treatment_executive.pdf
     May 01, 2011 - need for short-acting beta2-agonist inhalers for “quick relief” of asthma symptoms (≤ twice per week … The public was invited to comment on the Key Questions during a 4-week period. … of breathing retraining techniques that included participants aged 5 years or older, reported at 4 week … Another trial with a very intensive intervention reported a very large effect size at 2- and 4-week … percent predicted FEV1,compared with a 2.6 percentage point reduction in the control group at 8-week

272. Kravitz_ECCS2012 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/kravitz_eccs2012.pdf
     January 01, 2012 -  in  2 days to see how  you’re doing.” o “If you’re not feeling well by the beginning of next week

273. Horizon-Scan Research-Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/horizon-scan_research-protocol.pdf
     December 01, 2011 - Biotech Device Drug In Vitro Diagnostics Procedure/ Therapy Process Off-label Use Business Week … information on research on orthopedics; is part of OrthoSuperSite.com X X X X X X Orthopedics This Week

274. Rheumatoid-Arthritis-Medicine Surveillance (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/rheumatoid-arthritis-medicine_surveillance.pdf
     March 01, 2013 - radiographic outcomes than discontinuation upon starting etanercept in patients with rheumatoid arthritis: 52-week

275. Rheumatoid-Arthritis-Medicine Surveillance (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/rheumatoid-arthritis-medicine_surveillance.pdf
     March 01, 2013 - radiographic outcomes than discontinuation upon starting etanercept in patients with rheumatoid arthritis: 52-week

276. Long COVID Models of Care (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/long-covid-protocol.pdf
     February 18, 2023 - Long COVID Models of Care Evidence-based Practice Center Technical Brief Protocol Project Title: Long COVID Models of Care I. Background and Objectives for the Technical Brief A large, growing population of persons have experienced severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infectio…

277. Microsoft Word - 3-DKE274__ACEI-ARB-DRI__Comments_Disposition_Table-21_Jan_2011 cyk _2_.docx (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/ace-inhibitor-arb-update_disposition-comments.pdf
     October 07, 2011 - effectiveness research review is posted to the EHC Program Web site in draft form for public comment for a 4-week … The target dose is 32 mg once daily, which is achieved by doubling the dose at approximately 2-week

278. Glasgow.Presentation (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/interactive_media_glasgow_presentation.pdf
     January 01, 2009 - Usage  decreased  over  the  24-­‐week  intervention,  and  number   of  overall  

279. Surveillance Report: Masks for Prevention of COVID-19 in Community and Healthcare Settings (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/masks-prevention-covid-surveillance-report.pdf
     July 17, 2020 - Surveillance Report: Masks for Prevention of COVID-19 in Community and Healthcare Settings Surveillance Report: July 17, 2020 Masks for Prevention of COVID-19 in Community and Healthcare Settings: Surveillance Report Background This surveillance report summarizes the search and update for the rapid review and l…

280. Schedule of Visits and Use of Telemedicine for Routine Antenatal Care: A Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/antenatal-care.pdf
     January 01, 2020 - visits or their timing (unrelated to frequency of use of interventions) e.g. ultrasound (U/S) at the week … 18 vs. week 22 visit • Addition of interventions conducted during antenatal care for specific evaluation